vindesine has been researched along with Thrombopenia in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (50.00) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
| Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P | 1 |
| Guan, ZZ; Lin, H; Ling, JY; Luo, WB; Peng, RJ; Sun, XF; Xia, Y; Xiang, XJ; Zhen, ZJ; Zheng, L | 1 |
| Bedikian, AY; Bodey, GP; Gutterman, JU; Hersh, EM; Maroun, J; Valdivieso, M | 1 |
| Aisner, J; Bachur, NR; Egorin, MJ; Fuks, JZ; Ostrow, S; Van Echo, DA; Wiernik, PH | 1 |
| Brooks, RJ; Garewal, HS; Jones, SE; Miller, TP | 1 |
| Camacho, FJ; Kaplan, BH; O'Donnell, MR; Vogl, SE | 1 |
| Baker, LH; Costanzi, JJ; Quagliana, JM; Stephens, RL | 1 |
| Bezwoda, WR; Derman, DP; Nissenbaum, M; Weaving, A | 1 |
| Bedikian, AY; Bennetts, RW; Bodey, GP; Karlin, DA; Stroehlein, JR; Valdivieso, M | 1 |
| Haas, CD; Hoogstraten, B; Komp, D; Shepherd, DA; Vats, T; Vietti, T | 1 |
| Akira, M; Furuse, K; Kawahara, M; Kodama, N; Kubota, K; Kusunoki, Y; Nakajima, S; Negoro, S; Ogawara, M; Takada, M | 1 |
| Hara, N; Inutsuka, S; Kawasaki, M; Nakanishi, Y; Takayama, K; Tsuruta, N; Wakamatsu, K; Yatsunami, J | 1 |
| Haneda, H; Hayashi, T; Koizumi, M | 1 |
| Alietti, A; Baldini, L; Colombi, M; Guffanti, A; Latargia, ML; Maiolo, AT; Vener, C | 1 |
| Cvitkovic, E; de Cremoux, H; Huet, J; Martin, M; Monnet, I; Riggi, M; Ruffie, P; Saltiel, JC; Vergne, L; Voisin, S | 1 |
| Arai, N; Hara, A; Shirai, T; Umeda, M | 1 |
| Eguchi, K; Kojima, A; Miya, T; Ohe, Y; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Adachi, S; Hayashi, Y; Ito, G; Kato, M; Matsuura, T; Takeuchi, T; Yamada, Y; Yamamoto, K | 1 |
| Burke, MT; Casper, ES; Cibas, IR; Fiore, JJ; Gralla, RJ; Heelan, RT; Kelsen, DP; Kris, MG | 1 |
| Eguchi, K; Keicho, N; Miyaoka, H; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Shinkai, T; Suga, J; Tominaga, K | 1 |
| Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S | 1 |
10 trial(s) available for vindesine and Thrombopenia
| Article | Year |
|---|---|
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine | 2014 |
[Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Leukopenia; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Staging; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Vincristine; Vindesine | 2009 |
Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Japan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Prospective Studies; Regression Analysis; Remission Induction; Survival Rate; Thrombocytopenia; Vindesine | 1995 |
Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Recombinant Proteins; Remission Induction; Safety; Survival Rate; Thrombocytopenia; Vindesine; Vomiting | 1997 |
[An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Vindesine | 2000 |
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Humans; Lomustine; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Neoplasm Staging; Thrombocytopenia; Vindesine | 1991 |
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Creatinine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Peripheral Nervous System Diseases; Thrombocytopenia; Vinblastine; Vindesine | 1985 |
Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Random Allocation; Thrombocytopenia; Uremia; Vindesine | 1986 |
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Prospective Studies; Random Allocation; Skin Neoplasms; Thrombocytopenia; Vindesine; Vomiting | 1985 |
12 other study(ies) available for vindesine and Thrombopenia
| Article | Year |
|---|---|
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine | 2013 |
Evaluation of vindesine and MER in colorectal cancer.
Topics: Adult; Aged; Agranulocytosis; BCG Vaccine; Colonic Neoplasms; Drug Evaluation; Female; Fever; Humans; Immunotherapy; Injections, Intravenous; Male; Middle Aged; Peripheral Nervous System Diseases; Prognosis; Rectal Neoplasms; Thrombocytopenia; Vinblastine; Vindesine | 1980 |
Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.
Topics: Aged; Cisplatin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kinetics; Leukopenia; Lung Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Thrombocytopenia; Vinblastine; Vindesine | 1983 |
Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Resistance; Female; Humans; Leukopenia; Middle Aged; Mitomycin; Mitomycins; Pneumonia; Thrombocytopenia; Vinblastine; Vindesine | 1983 |
Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Nervous System; Thrombocytopenia; Vinblastine; Vindesine | 1984 |
Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
Topics: Adult; Aged; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nervous System Diseases; Skin Neoplasms; Thrombocytopenia; Vinblastine; Vindesine | 1984 |
Treatment of esophageal cancer with vindesine: an open trial.
Topics: Drug Evaluation; Esophageal Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Serum Albumin; Thrombocytopenia; Time Factors; Vinblastine; Vindesine | 1984 |
Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukocyte Count; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Platelet Count; Prognosis; Rectal Neoplasms; Semustine; Thrombocytopenia; Vinblastine; Vindesine | 1982 |
Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study.
Topics: Adolescent; Agranulocytosis; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Humans; Leukemia; Pain; Pilot Projects; Thrombocytopenia; Vinblastine; Vindesine | 1980 |
[Salvage chemotherapy with IMV-triple P for relapsed or refractory malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Female; Heart; Humans; Ifosfamide; Leukopenia; Lymphoma; Male; Middle Aged; Mitoxantrone; Peplomycin; Prednisolone; Procarbazine; Remission Induction; Survival Rate; Thrombocytopenia; Vindesine | 1991 |
[The relation between myelotoxicity and performance status or aging in chemotherapy of non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Thrombocytopenia; Vindesine | 1991 |
[Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Survival Rate; Thrombocytopenia; Vindesine | 1990 |